| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4131239 | Diagnostic Histopathology | 2011 | 7 Pages |
Abstract
Recent developments in personalized medicine and pharmacogenomics necessitate the availability in adequate quantities of well preserved and uncontaminated, fresh representative material. The value of onsite, accurate interpretation of cellular samples in procurement and handling of such specimens cannot be over emphasized. This paper summarizes the present practices and recommendations for improvements both in the quality of specimens and delivery of FNA services.
Related Topics
Health Sciences
Medicine and Dentistry
Pathology and Medical Technology
Authors
Prabodh K. Gupta,